Global Leuprolide Market Research Report 2023

Leuprolide Market

Leuprolide belongs to the general class of drugs known as hormones or hormone antagonists. It is a synthetic 9 residue peptide analog of gonadotropin releasing hormone. Leuprolide is used to treat advanced prostate cancer. It is also used to treat uterine fibroids and endometriosis. Leuprolide is also under investigation for possible use in the treatment of mild to moderate Alzheimer's disease.

The global Leuprolide market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Leuprolide is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Leuprolide is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Leuprolide in Breast Cancer is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Leuprolide include TOLMAR PHARMACEUTICALS, Sanofi, Teva, Sandoz (Novartis), Sun Pharmaceutical, AbbVie, Bayer, Takeda and Beijing Boente Pharmaceutical, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Leuprolide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Leuprolide.

The Leuprolide market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Leuprolide market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Leuprolide companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Scope of Leuprolide Market Report

Core Chapters

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Leuprolide Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Subcutaneous

1.2.3 Topical

1.3 Market by Application

1.3.1 Global Leuprolide Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Breast Cancer

1.3.3 Endometriosis

1.3.4 Precocious Puberty

1.3.5 Prostate Cancer

1.3.6 Uterine Fibrosis

1.3.7 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Leuprolide Market Perspective (2018-2029)

2.2 Leuprolide Growth Trends by Region

2.2.1 Global Leuprolide Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Leuprolide Historic Market Size by Region (2018-2023)

2.2.3 Leuprolide Forecasted Market Size by Region (2024-2029)

2.3 Leuprolide Market Dynamics

2.3.1 Leuprolide Industry Trends

2.3.2 Leuprolide Market Drivers

2.3.3 Leuprolide Market Challenges

2.3.4 Leuprolide Market Restraints

3.1 Global Top Leuprolide Players by Revenue

3.1.1 Global Top Leuprolide Players by Revenue (2018-2023)

3.1.2 Global Leuprolide Revenue Market Share by Players (2018-2023)

3.2 Global Leuprolide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Leuprolide Revenue

3.4 Global Leuprolide Market Concentration Ratio

3.4.1 Global Leuprolide Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Leuprolide Revenue in 2022

3.5 Leuprolide Key Players Head office and Area Served

3.6 Key Players Leuprolide Product Solution and Service

3.7 Date of Enter into Leuprolide Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Leuprolide Historic Market Size by Type (2018-2023)

4.2 Global Leuprolide Forecasted Market Size by Type (2024-2029)

5.1 Global Leuprolide Historic Market Size by Application (2018-2023)

5.2 Global Leuprolide Forecasted Market Size by Application (2024-2029)

6.1 North America Leuprolide Market Size (2018-2029)

6.2 North America Leuprolide Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Leuprolide Market Size by Country (2018-2023)

6.4 North America Leuprolide Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Leuprolide Market Size (2018-2029)

7.2 Europe Leuprolide Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Leuprolide Market Size by Country (2018-2023)

7.4 Europe Leuprolide Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Leuprolide Market Size (2018-2029)

8.2 Asia-Pacific Leuprolide Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Leuprolide Market Size by Region (2018-2023)

8.4 Asia-Pacific Leuprolide Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Leuprolide Market Size (2018-2029)

9.2 Latin America Leuprolide Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Leuprolide Market Size by Country (2018-2023)

9.4 Latin America Leuprolide Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Leuprolide Market Size (2018-2029)

10.2 Middle East & Africa Leuprolide Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Leuprolide Market Size by Country (2018-2023)

10.4 Middle East & Africa Leuprolide Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 TOLMAR PHARMACEUTICALS

11.1.1 TOLMAR PHARMACEUTICALS Company Detail

11.1.2 TOLMAR PHARMACEUTICALS Business Overview

11.1.3 TOLMAR PHARMACEUTICALS Leuprolide Introduction

11.1.4 TOLMAR PHARMACEUTICALS Revenue in Leuprolide Business (2018-2023)

11.1.5 TOLMAR PHARMACEUTICALS Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Detail

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Leuprolide Introduction

11.2.4 Sanofi Revenue in Leuprolide Business (2018-2023)

11.2.5 Sanofi Recent Development

11.3 Teva

11.3.1 Teva Company Detail

11.3.2 Teva Business Overview

11.3.3 Teva Leuprolide Introduction

11.3.4 Teva Revenue in Leuprolide Business (2018-2023)

11.3.5 Teva Recent Development

11.4 Sandoz (Novartis)

11.4.1 Sandoz (Novartis) Company Detail

11.4.2 Sandoz (Novartis) Business Overview

11.4.3 Sandoz (Novartis) Leuprolide Introduction

11.4.4 Sandoz (Novartis) Revenue in Leuprolide Business (2018-2023)

11.4.5 Sandoz (Novartis) Recent Development

11.5 Sun Pharmaceutical

11.5.1 Sun Pharmaceutical Company Detail

11.5.2 Sun Pharmaceutical Business Overview

11.5.3 Sun Pharmaceutical Leuprolide Introduction

11.5.4 Sun Pharmaceutical Revenue in Leuprolide Business (2018-2023)

11.5.5 Sun Pharmaceutical Recent Development

11.6 AbbVie

11.6.1 AbbVie Company Detail

11.6.2 AbbVie Business Overview

11.6.3 AbbVie Leuprolide Introduction

11.6.4 AbbVie Revenue in Leuprolide Business (2018-2023)

11.6.5 AbbVie Recent Development

11.7 Bayer

11.7.1 Bayer Company Detail

11.7.2 Bayer Business Overview

11.7.3 Bayer Leuprolide Introduction

11.7.4 Bayer Revenue in Leuprolide Business (2018-2023)

11.7.5 Bayer Recent Development

11.8 Takeda

11.8.1 Takeda Company Detail

11.8.2 Takeda Business Overview

11.8.3 Takeda Leuprolide Introduction

11.8.4 Takeda Revenue in Leuprolide Business (2018-2023)

11.8.5 Takeda Recent Development

11.9 Beijing Boente Pharmaceutical

11.9.1 Beijing Boente Pharmaceutical Company Detail

11.9.2 Beijing Boente Pharmaceutical Business Overview

11.9.3 Beijing Boente Pharmaceutical Leuprolide Introduction

11.9.4 Beijing Boente Pharmaceutical Revenue in Leuprolide Business (2018-2023)

11.9.5 Beijing Boente Pharmaceutical Recent Development

11.10 Livzon Pharmaceutical

11.10.1 Livzon Pharmaceutical Company Detail

11.10.2 Livzon Pharmaceutical Business Overview

11.10.3 Livzon Pharmaceutical Leuprolide Introduction

11.10.4 Livzon Pharmaceutical Revenue in Leuprolide Business (2018-2023)

11.10.5 Livzon Pharmaceutical Recent Development

11.11 Selleck

11.11.1 Selleck Company Detail

11.11.2 Selleck Business Overview

11.11.3 Selleck Leuprolide Introduction

11.11.4 Selleck Revenue in Leuprolide Business (2018-2023)

11.11.5 Selleck Recent Development

11.12 Hangzhou Peptide Biochemical

11.12.1 Hangzhou Peptide Biochemical Company Detail

11.12.2 Hangzhou Peptide Biochemical Business Overview

11.12.3 Hangzhou Peptide Biochemical Leuprolide Introduction

11.12.4 Hangzhou Peptide Biochemical Revenue in Leuprolide Business (2018-2023)

11.12.5 Hangzhou Peptide Biochemical Recent Development

11.13 Chengdu Shenguo Biological Pharmaceutical

11.13.1 Chengdu Shenguo Biological Pharmaceutical Company Detail

11.13.2 Chengdu Shenguo Biological Pharmaceutical Business Overview

11.13.3 Chengdu Shenguo Biological Pharmaceutical Leuprolide Introduction

11.13.4 Chengdu Shenguo Biological Pharmaceutical Revenue in Leuprolide Business (2018-2023)

11.13.5 Chengdu Shenguo Biological Pharmaceutical Recent Development

11.14 SciAnda Pharma

11.14.1 SciAnda Pharma Company Detail

11.14.2 SciAnda Pharma Business Overview

11.14.3 SciAnda Pharma Leuprolide Introduction

11.14.4 SciAnda Pharma Revenue in Leuprolide Business (2018-2023)

11.14.5 SciAnda Pharma Recent Development

11.15 Daewoong

11.15.1 Daewoong Company Detail

11.15.2 Daewoong Business Overview

11.15.3 Daewoong Leuprolide Introduction

11.15.4 Daewoong Revenue in Leuprolide Business (2018-2023)

11.15.5 Daewoong Recent Development

11.16 GP Pharm

11.16.1 GP Pharm Company Detail

11.16.2 GP Pharm Business Overview

11.16.3 GP Pharm Leuprolide Introduction

11.16.4 GP Pharm Revenue in Leuprolide Business (2018-2023)

11.16.5 GP Pharm Recent Development

11.17 Enteris BioPharma

11.17.1 Enteris BioPharma Company Detail

11.17.2 Enteris BioPharma Business Overview

11.17.3 Enteris BioPharma Leuprolide Introduction

11.17.4 Enteris BioPharma Revenue in Leuprolide Business (2018-2023)

11.17.5 Enteris BioPharma Recent Development

11.18 Chong Kun Dang

11.18.1 Chong Kun Dang Company Detail

11.18.2 Chong Kun Dang Business Overview

11.18.3 Chong Kun Dang Leuprolide Introduction

11.18.4 Chong Kun Dang Revenue in Leuprolide Business (2018-2023)

11.18.5 Chong Kun Dang Recent Development

11.19 Leadiant Biosciences

11.19.1 Leadiant Biosciences Company Detail

11.19.2 Leadiant Biosciences Business Overview

11.19.3 Leadiant Biosciences Leuprolide Introduction

11.19.4 Leadiant Biosciences Revenue in Leuprolide Business (2018-2023)

11.19.5 Leadiant Biosciences Recent Development

11.20 Hikma Pharmaceuticals

11.20.1 Hikma Pharmaceuticals Company Detail

11.20.2 Hikma Pharmaceuticals Business Overview

11.20.3 Hikma Pharmaceuticals Leuprolide Introduction

11.20.4 Hikma Pharmaceuticals Revenue in Leuprolide Business (2018-2023)

11.20.5 Hikma Pharmaceuticals Recent Development

11.21 Lee Pharma

11.21.1 Lee Pharma Company Detail

11.21.2 Lee Pharma Business Overview

11.21.3 Lee Pharma Leuprolide Introduction

11.21.4 Lee Pharma Revenue in Leuprolide Business (2018-2023)

11.21.5 Lee Pharma Recent Development

11.22 Hanall

11.22.1 Hanall Company Detail

11.22.2 Hanall Business Overview

11.22.3 Hanall Leuprolide Introduction

11.22.4 Hanall Revenue in Leuprolide Business (2018-2023)

11.22.5 Hanall Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Leuprolide Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Subcutaneous

    Table 3. Key Players of Topical

    Table 4. Global Leuprolide Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 5. Global Leuprolide Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 6. Global Leuprolide Market Size by Region (2018-2023) & (US$ Million)

    Table 7. Global Leuprolide Market Share by Region (2018-2023)

    Table 8. Global Leuprolide Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 9. Global Leuprolide Market Share by Region (2024-2029)

    Table 10. Leuprolide Market Trends

    Table 11. Leuprolide Market Drivers

    Table 12. Leuprolide Market Challenges

    Table 13. Leuprolide Market Restraints

    Table 14. Global Leuprolide Revenue by Players (2018-2023) & (US$ Million)

    Table 15. Global Leuprolide Market Share by Players (2018-2023)

    Table 16. Global Top Leuprolide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leuprolide as of 2022)

    Table 17. Ranking of Global Top Leuprolide Companies by Revenue (US$ Million) in 2022

    Table 18. Global 5 Largest Players Market Share by Leuprolide Revenue (CR5 and HHI) & (2018-2023)

    Table 19. Key Players Headquarters and Area Served

    Table 20. Key Players Leuprolide Product Solution and Service

    Table 21. Date of Enter into Leuprolide Market

    Table 22. Mergers & Acquisitions, Expansion Plans

    Table 23. Global Leuprolide Market Size by Type (2018-2023) & (US$ Million)

    Table 24. Global Leuprolide Revenue Market Share by Type (2018-2023)

    Table 25. Global Leuprolide Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 26. Global Leuprolide Revenue Market Share by Type (2024-2029)

    Table 27. Global Leuprolide Market Size by Application (2018-2023) & (US$ Million)

    Table 28. Global Leuprolide Revenue Market Share by Application (2018-2023)

    Table 29. Global Leuprolide Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 30. Global Leuprolide Revenue Market Share by Application (2024-2029)

    Table 31. North America Leuprolide Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 32. North America Leuprolide Market Size by Country (2018-2023) & (US$ Million)

    Table 33. North America Leuprolide Market Size by Country (2024-2029) & (US$ Million)

    Table 34. Europe Leuprolide Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 35. Europe Leuprolide Market Size by Country (2018-2023) & (US$ Million)

    Table 36. Europe Leuprolide Market Size by Country (2024-2029) & (US$ Million)

    Table 37. Asia-Pacific Leuprolide Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 38. Asia-Pacific Leuprolide Market Size by Region (2018-2023) & (US$ Million)

    Table 39. Asia-Pacific Leuprolide Market Size by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Leuprolide Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 41. Latin America Leuprolide Market Size by Country (2018-2023) & (US$ Million)

    Table 42. Latin America Leuprolide Market Size by Country (2024-2029) & (US$ Million)

    Table 43. Middle East & Africa Leuprolide Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 44. Middle East & Africa Leuprolide Market Size by Country (2018-2023) & (US$ Million)

    Table 45. Middle East & Africa Leuprolide Market Size by Country (2024-2029) & (US$ Million)

    Table 46. TOLMAR PHARMACEUTICALS Company Detail

    Table 47. TOLMAR PHARMACEUTICALS Business Overview

    Table 48. TOLMAR PHARMACEUTICALS Leuprolide Product

    Table 49. TOLMAR PHARMACEUTICALS Revenue in Leuprolide Business (2018-2023) & (US$ Million)

    Table 50. TOLMAR PHARMACEUTICALS Recent Development

    Table 51. Sanofi Company Detail

    Table 52. Sanofi Business Overview

    Table 53. Sanofi Leuprolide Product

    Table 54. Sanofi Revenue in Leuprolide Business (2018-2023) & (US$ Million)

    Table 55. Sanofi Recent Development

    Table 56. Teva Company Detail

    Table 57. Teva Business Overview

    Table 58. Teva Leuprolide Product

    Table 59. Teva Revenue in Leuprolide Business (2018-2023) & (US$ Million)

    Table 60. Teva Recent Development

    Table 61. Sandoz (Novartis) Company Detail

    Table 62. Sandoz (Novartis) Business Overview

    Table 63. Sandoz (Novartis) Leuprolide Product

    Table 64. Sandoz (Novartis) Revenue in Leuprolide Business (2018-2023) & (US$ Million)

    Table 65. Sandoz (Novartis) Recent Development

    Table 66. Sun Pharmaceutical Company Detail

    Table 67. Sun Pharmaceutical Business Overview

    Table 68. Sun Pharmaceutical Leuprolide Product

    Table 69. Sun Pharmaceutical Revenue in Leuprolide Business (2018-2023) & (US$ Million)

    Table 70. Sun Pharmaceutical Recent Development

    Table 71. AbbVie Company Detail

    Table 72. AbbVie Business Overview

    Table 73. AbbVie Leuprolide Product

    Table 74. AbbVie Revenue in Leuprolide Business (2018-2023) & (US$ Million)

    Table 75. AbbVie Recent Development

    Table 76. Bayer Company Detail

    Table 77. Bayer Business Overview

    Table 78. Bayer Leuprolide Product

    Table 79. Bayer Revenue in Leuprolide Business (2018-2023) & (US$ Million)

    Table 80. Bayer Recent Development

    Table 81. Takeda Company Detail

    Table 82. Takeda Business Overview

    Table 83. Takeda Leuprolide Product

    Table 84. Takeda Revenue in Leuprolide Business (2018-2023) & (US$ Million)

    Table 85. Takeda Recent Development

    Table 86. Beijing Boente Pharmaceutical Company Detail

    Table 87. Beijing Boente Pharmaceutical Business Overview

    Table 88. Beijing Boente Pharmaceutical Leuprolide Product

    Table 89. Beijing Boente Pharmaceutical Revenue in Leuprolide Business (2018-2023) & (US$ Million)

    Table 90. Beijing Boente Pharmaceutical Recent Development

    Table 91. Livzon Pharmaceutical Company Detail

    Table 92. Livzon Pharmaceutical Business Overview

    Table 93. Livzon Pharmaceutical Leuprolide Product

    Table 94. Livzon Pharmaceutical Revenue in Leuprolide Business (2018-2023) & (US$ Million)

    Table 95. Livzon Pharmaceutical Recent Development

    Table 96. Selleck Company Detail

    Table 97. Selleck Business Overview

    Table 98. Selleck Leuprolide Product

    Table 99. Selleck Revenue in Leuprolide Business (2018-2023) & (US$ Million)

    Table 100. Selleck Recent Development

    Table 101. Hangzhou Peptide Biochemical Company Detail

    Table 102. Hangzhou Peptide Biochemical Business Overview

    Table 103. Hangzhou Peptide Biochemical Leuprolide Product

    Table 104. Hangzhou Peptide Biochemical Revenue in Leuprolide Business (2018-2023) & (US$ Million)

    Table 105. Hangzhou Peptide Biochemical Recent Development

    Table 106. Chengdu Shenguo Biological Pharmaceutical Company Detail

    Table 107. Chengdu Shenguo Biological Pharmaceutical Business Overview

    Table 108. Chengdu Shenguo Biological Pharmaceutical Leuprolide Product

    Table 109. Chengdu Shenguo Biological Pharmaceutical Revenue in Leuprolide Business (2018-2023) & (US$ Million)

    Table 110. Chengdu Shenguo Biological Pharmaceutical Recent Development

    Table 111. SciAnda Pharma Company Detail

    Table 112. SciAnda Pharma Business Overview

    Table 113. SciAnda Pharma Leuprolide Product

    Table 114. SciAnda Pharma Revenue in Leuprolide Business (2018-2023) & (US$ Million)

    Table 115. SciAnda Pharma Recent Development

    Table 116. Daewoong Company Detail

    Table 117. Daewoong Business Overview

    Table 118. Daewoong Leuprolide Product

    Table 119. Daewoong Revenue in Leuprolide Business (2018-2023) & (US$ Million)

    Table 120. Daewoong Recent Development

    Table 121. GP Pharm Company Detail

    Table 122. GP Pharm Business Overview

    Table 123. GP Pharm Leuprolide Product

    Table 124. GP Pharm Revenue in Leuprolide Business (2018-2023) & (US$ Million)

    Table 125. GP Pharm Recent Development

    Table 126. Enteris BioPharma Company Detail

    Table 127. Enteris BioPharma Business Overview

    Table 128. Enteris BioPharma Leuprolide Product

    Table 129. Enteris BioPharma Revenue in Leuprolide Business (2018-2023) & (US$ Million)

    Table 130. Enteris BioPharma Recent Development

    Table 131. Chong Kun Dang Company Detail

    Table 132. Chong Kun Dang Business Overview

    Table 133. Chong Kun Dang Leuprolide Product

    Table 134. Chong Kun Dang Revenue in Leuprolide Business (2018-2023) & (US$ Million)

    Table 135. Chong Kun Dang Recent Development

    Table 136. Leadiant Biosciences Company Detail

    Table 137. Leadiant Biosciences Business Overview

    Table 138. Leadiant Biosciences Leuprolide Product

    Table 139. Leadiant Biosciences Revenue in Leuprolide Business (2018-2023) & (US$ Million)

    Table 140. Leadiant Biosciences Recent Development

    Table 141. Hikma Pharmaceuticals Company Detail

    Table 142. Hikma Pharmaceuticals Business Overview

    Table 143. Hikma Pharmaceuticals Leuprolide Product

    Table 144. Hikma Pharmaceuticals Revenue in Leuprolide Business (2018-2023) & (US$ Million)

    Table 145. Hikma Pharmaceuticals Recent Development

    Table 146. Lee Pharma Company Detail

    Table 147. Lee Pharma Business Overview

    Table 148. Lee Pharma Leuprolide Product

    Table 149. Lee Pharma Revenue in Leuprolide Business (2018-2023) & (US$ Million)

    Table 150. Lee Pharma Recent Development

    Table 151. Hanall Company Detail

    Table 152. Hanall Business Overview

    Table 153. Hanall Leuprolide Product

    Table 154. Hanall Revenue in Leuprolide Business (2018-2023) & (US$ Million)

    Table 155. Hanall Recent Development

    Table 156. Research Programs/Design for This Report

    Table 157. Key Data Information from Secondary Sources

    Table 158. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Leuprolide Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Leuprolide Market Share by Type: 2022 VS 2029

    Figure 3. Subcutaneous Features

    Figure 4. Topical Features

    Figure 5. Global Leuprolide Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 6. Global Leuprolide Market Share by Application: 2022 VS 2029

    Figure 7. Breast Cancer Case Studies

    Figure 8. Endometriosis Case Studies

    Figure 9. Precocious Puberty Case Studies

    Figure 10. Prostate Cancer Case Studies

    Figure 11. Uterine Fibrosis Case Studies

    Figure 12. Other Case Studies

    Figure 13. Leuprolide Report Years Considered

    Figure 14. Global Leuprolide Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Leuprolide Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Leuprolide Market Share by Region: 2022 VS 2029

    Figure 17. Global Leuprolide Market Share by Players in 2022

    Figure 18. Global Top Leuprolide Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leuprolide as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Leuprolide Revenue in 2022

    Figure 20. North America Leuprolide Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Leuprolide Market Share by Country (2018-2029)

    Figure 22. United States Leuprolide Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Leuprolide Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Leuprolide Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Leuprolide Market Share by Country (2018-2029)

    Figure 26. Germany Leuprolide Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Leuprolide Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Leuprolide Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Leuprolide Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Leuprolide Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Leuprolide Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Leuprolide Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Leuprolide Market Share by Region (2018-2029)

    Figure 34. China Leuprolide Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Leuprolide Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Leuprolide Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Leuprolide Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Leuprolide Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Leuprolide Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Leuprolide Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Leuprolide Market Share by Country (2018-2029)

    Figure 42. Mexico Leuprolide Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Leuprolide Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Leuprolide Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Leuprolide Market Share by Country (2018-2029)

    Figure 46. Turkey Leuprolide Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Leuprolide Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. TOLMAR PHARMACEUTICALS Revenue Growth Rate in Leuprolide Business (2018-2023)

    Figure 49. Sanofi Revenue Growth Rate in Leuprolide Business (2018-2023)

    Figure 50. Teva Revenue Growth Rate in Leuprolide Business (2018-2023)

    Figure 51. Sandoz (Novartis) Revenue Growth Rate in Leuprolide Business (2018-2023)

    Figure 52. Sun Pharmaceutical Revenue Growth Rate in Leuprolide Business (2018-2023)

    Figure 53. AbbVie Revenue Growth Rate in Leuprolide Business (2018-2023)

    Figure 54. Bayer Revenue Growth Rate in Leuprolide Business (2018-2023)

    Figure 55. Takeda Revenue Growth Rate in Leuprolide Business (2018-2023)

    Figure 56. Beijing Boente Pharmaceutical Revenue Growth Rate in Leuprolide Business (2018-2023)

    Figure 57. Livzon Pharmaceutical Revenue Growth Rate in Leuprolide Business (2018-2023)

    Figure 58. Selleck Revenue Growth Rate in Leuprolide Business (2018-2023)

    Figure 59. Hangzhou Peptide Biochemical Revenue Growth Rate in Leuprolide Business (2018-2023)

    Figure 60. Chengdu Shenguo Biological Pharmaceutical Revenue Growth Rate in Leuprolide Business (2018-2023)

    Figure 61. SciAnda Pharma Revenue Growth Rate in Leuprolide Business (2018-2023)

    Figure 62. Daewoong Revenue Growth Rate in Leuprolide Business (2018-2023)

    Figure 63. GP Pharm Revenue Growth Rate in Leuprolide Business (2018-2023)

    Figure 64. Enteris BioPharma Revenue Growth Rate in Leuprolide Business (2018-2023)

    Figure 65. Chong Kun Dang Revenue Growth Rate in Leuprolide Business (2018-2023)

    Figure 66. Leadiant Biosciences Revenue Growth Rate in Leuprolide Business (2018-2023)

    Figure 67. Hikma Pharmaceuticals Revenue Growth Rate in Leuprolide Business (2018-2023)

    Figure 68. Lee Pharma Revenue Growth Rate in Leuprolide Business (2018-2023)

    Figure 69. Hanall Revenue Growth Rate in Leuprolide Business (2018-2023)

    Figure 70. Bottom-up and Top-down Approaches for This Report

    Figure 71. Data Triangulation

    Figure 72. Key Executives Interviewed